Cargando…

A non-coding GWAS variant impacts anthracycline-induced cardiotoxic phenotypes in human iPSC-derived cardiomyocytes

Anthracyclines, widely used to treat breast cancer, have the potential for cardiotoxicity. We have previously identified and validated a germline single nucleotide polymorphism, rs28714259, associated with an increased risk of anthracycline-induced heart failure. We now provide insights into the mec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Xi, Shen, Fei, Jiang, Guanglong, Xue, Gloria, Philips, Santosh, Gardner, Laura, Cunningham, Geneva, Bales, Casey, Cantor, Erica, Schneider, Bryan Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9684507/ https://www.ncbi.nlm.nih.gov/pubmed/36418322 http://dx.doi.org/10.1038/s41467-022-34917-y

Ejemplares similares

Identification of genomic biomarkers for anthracycline-induced cardiotoxicity in human iPSC-derived cardiomyocytes: an in vitro repeated exposure toxicity approach for safety assessment
por: Chaudhari, Umesh, et al.
Publicado: (2015)

Maturing iPSC-Derived Cardiomyocytes
por: Tang, Bor Luen
Publicado: (2020)

The impact of SBF2 on taxane-induced peripheral neuropathy
por: Cunningham, Geneva M., et al.
Publicado: (2022)

The Utilisation of Hydrogels for iPSC-Cardiomyocyte Research
por: Patel, Leena, et al.
Publicado: (2023)

Cardiotoxicity assessment using 3D vascularized cardiac tissue consisting of human iPSC-derived cardiomyocytes and fibroblasts
por: Tadano, Kiyoshi, et al.
Publicado: (2021)

Passage number affects differentiation of sensory neurons from human induced pluripotent stem cells
por: Cantor, Erica L., et al.
Publicado: (2022)

Cardiotoxicity of Anthracyclines
por: Cardinale, Daniela, et al.
Publicado: (2020)

Anthracycline-Induced Cardiotoxicity: Molecular Insights Obtained from Human-Induced Pluripotent Stem Cell–Derived Cardiomyocytes (hiPSC-CMs)
por: Bozza, William P., et al.
Publicado: (2021)

Transplantation of purified iPSC-derived cardiomyocytes in myocardial infarction
por: Rojas, Sebastian V., et al.
Publicado: (2017)

Analysis of Drug Effects on iPSC Cardiomyocytes with Machine Learning
por: Juhola, Martti, et al.
Publicado: (2020)

The Structural and the Functional Aspects of Intercellular Communication in iPSC-Cardiomyocytes
por: Kiss, Eva, et al.
Publicado: (2022)

Dynamic alternative polyadenylation during iPSC differentiation into cardiomyocytes
por: Yang, Yanbo, et al.
Publicado: (2022)

Modeling Cardiotoxicity in Pediatric Oncology Patients Using Patient-Specific iPSC-Derived Cardiomyocytes Reveals Downregulation of Cardioprotective microRNAs
por: Reinal, Ignacio, et al.
Publicado: (2023)

Anthracycline Chemotherapy and Cardiotoxicity
por: McGowan, John V, et al.
Publicado: (2017)

The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC-derived cardiomyocytes
por: Necela, Brian M., et al.
Publicado: (2017)

Unchain My Heart: Integrins at the Basis of iPSC Cardiomyocyte Differentiation
por: Santoro, Rosaria, et al.
Publicado: (2019)

Space microgravity improves proliferation of human iPSC-derived cardiomyocytes
por: Rampoldi, Antonio, et al.
Publicado: (2022)

Gene Modulation with CRISPR-based Tools in Human iPSC-Cardiomyocytes
por: Han, Julie Leann, et al.
Publicado: (2023)

Determining the genetic basis of anthracycline-cardiotoxicity by molecular response QTL mapping in induced cardiomyocytes
por: Knowles, David A, et al.
Publicado: (2018)

A Comparative Assessment of Human and Chimpanzee iPSC-derived Cardiomyocytes with Primary Heart Tissues
por: Pavlovic, Bryan J., et al.
Publicado: (2018)

The role of iron in anthracycline cardiotoxicity
por: Gammella, Elena, et al.
Publicado: (2014)

Updates in Anthracycline-Mediated Cardiotoxicity
por: Nebigil, Canan G., et al.
Publicado: (2018)

Metabolic Aspects of Anthracycline Cardiotoxicity
por: Russo, Michele, et al.
Publicado: (2021)

Genetics of Anthracycline-Associated Cardiotoxicity
por: Al-Otaibi, Talal Khalid, et al.
Publicado: (2022)

Anthracycline-induced cardiotoxicity and senescence
por: Booth, Laura K., et al.
Publicado: (2022)

Serum of patients with acute myocardial infarction prevents inflammation in iPSC-cardiomyocytes
por: Sattler, Katherine, et al.
Publicado: (2019)

Rapid Assessment of Proarrhythmic Potential Using Human iPSC-Derived Cardiomyocytes
por: Geiger, Robert M., et al.
Publicado: (2020)

iPSC-Cardiomyocyte Models of Brugada Syndrome—Achievements, Challenges and Future Perspectives
por: Nijak, Aleksandra, et al.
Publicado: (2021)

Morpho-functional comparison of differentiation protocols to create iPSC-derived cardiomyocytes
por: Nijak, Aleksandra, et al.
Publicado: (2022)

Sarcomere Disassembly and Transfection Efficiency in Proliferating Human iPSC-Derived Cardiomyocytes
por: Yuan, Qianliang, et al.
Publicado: (2022)

Functional and molecular effects of TNF-α on human iPSC-derived cardiomyocytes
por: Saraf, Anita, et al.
Publicado: (2021)

Human iPSC-Cardiomyocytes as an Experimental Model to Study Epigenetic Modifiers of Electrophysiology
por: Pozo, Maria R., et al.
Publicado: (2022)

ACTN2 Mutant Causes Proteopathy in Human iPSC-Derived Cardiomyocytes
por: Zech, Antonia T. L., et al.
Publicado: (2022)

Selective protection of human cardiomyocytes from anthracycline cardiotoxicity by small molecule inhibitors of MAP4K4
por: Golforoush, Pelin A., et al.
Publicado: (2020)

Comparison of Zebrafish Larvae and hiPSC Cardiomyocytes for Predicting Drug-Induced Cardiotoxicity in Humans
por: Dyballa, Sylvia, et al.
Publicado: (2019)

Co-culture with neonatal cardiomyocytes enhances the proliferation of iPSC-derived cardiomyocytes via FAK/JNK signaling
por: Ou, Dongbo, et al.
Publicado: (2016)

Anthracycline Cardiotoxicity: Prevalence, Pathogenesis and Treatment
por: Volkova, Maria, et al.
Publicado: (2011)

Cardiotoxicity of anthracycline therapy: current perspectives
por: Valcovici, Mihaela, et al.
Publicado: (2016)

Risk Factors for Anthracycline-Induced Cardiotoxicity
por: Qiu, Shuo, et al.
Publicado: (2021)

Coronary microcirculation damage in anthracycline cardiotoxicity
por: Galán-Arriola, Carlos, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nocq6qg1o7sub7srq94tjjt48j